Data from the RestorAATion-2 clinical trial of WVE-006 (GalNAc-RNA editing), including new data from the 400 mg multidose ...
Life science campuses of yesteryear' tended to be remote, all-work-no-play settings Today's versions are city-centered and ...
Q4 2025 earnings call recap: 60% revenue growth, 2026 guidance of $60–$62M, PEDD/TriNav expansion, funding and risks—read now.
The project is part of the up to $30 million investment in biomanufacturing workforce development launched in September 2025. The city of New Albany pledged an additional $5 million to the project ...
Forma Life Sciences, which inherited BioDuro’s California production operations earlier this year, has officially ...
Turco’s last day will be March 11. His successor will inherit an agency with big ambitions, and a limited time to prove its worth.
Venture capital firm Portal Innovations is planning to open a 30,000-square-foot science incubator in Salt Lake City while ...
AWS is launching Amazon Connect Health, handling patient calls, clinical documentation and billing codes in a new challenge ...
The transition from non-life to life was very likely aided by an asteroid hitting Earth, prebiotic chemistry, molecular ...
BNY Mellon Small/Mid Cap Growth Fund (Class A shares at NAV) outperformed its benchmark, the Russell 2500 Growth Index, during the fourth quarter of 2025.
How do biological cells join forces to form a structure? In her Ph.D. research, Daphne Nesenberend uses mathematics to show ...
After delivering solid sales growth in a difficult 2025, Germany’s Merck KGaA may have a tougher go of things this year, which the company is crediting in part to a predicted onslaught of U.S.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results